D.A. Davidson & Co. Boston Scientific Corp Transaction History

D.A. Davidson & Co.

$13.8 Billion
Q2 2025

A detailed history of D.A. Davidson & Co. transactions in Boston Scientific Corp stock. As of the latest transaction made, D.A. Davidson & Co. holds 12,632 shares of BSX stock, worth $1.24 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

12,632

Previous 11,536 9.5%

Holding current value

$1.24 Million

Previous $1.16 Million 16.6%

% of portfolio

0.01%

Previous 0.01%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 30, 2025	BUY	$89.7 - $107.41 $98,311 - $117,721	1,096 Added 9.5%	12,632 $1.36 Million
Q1 2025 Apr 28, 2025	BUY	$89.38 - $106.18 $45,047 - $53,514	504 Added 4.57%	11,536 $1.16 Million
Q4 2024 Jan 31, 2025	BUY	$83.62 - $91.5 $7,274 - $7,960	87 Added 0.79%	11,032 $985,000
Q3 2024 Nov 13, 2024	BUY	$72.96 - $84.0 $24,952 - $28,728	342 Added 3.23%	10,945 $917,000
Q2 2024 Jul 31, 2024	BUY	$67.33 - $77.71 $12,388 - $14,298	184 Added 1.77%	10,603 $816,000
Q1 2024 May 13, 2024	BUY	$57.6 - $68.62 $59,846 - $71,296	1,039 Added 11.08%	10,419 $713,000
Q4 2023 Feb 09, 2024	BUY	$48.64 - $57.81 $25,730 - $30,581	529 Added 5.98%	9,380 $542,000
Q3 2023 Nov 08, 2023	BUY	$50.19 - $54.68 $15,609 - $17,005	311 Added 3.64%	8,851 $467,000
Q2 2023 Aug 10, 2023	BUY	$49.72 - $54.64 $5,518 - $6,065	111 Added 1.32%	8,540 $461,000
Q1 2023 Apr 25, 2023	SELL	$45.09 - $50.03 $63,126 - $70,042	-1,400 Reduced 14.24%	8,429 $421,000
Q4 2022 Feb 03, 2023	SELL	$39.56 - $47.22 $14,676 - $17,518	-371 Reduced 3.64%	9,829 $454,000
Q3 2022 Nov 07, 2022	BUY	$36.71 - $109.66 $6,277 - $18,751	171 Added 1.71%	10,200 $395,000
Q2 2022 Jul 28, 2022	BUY	$35.24 - $47.1 $58,674 - $78,421	1,665 Added 19.91%	10,029 $374,000
Q1 2022 May 12, 2022	BUY	$40.9 - $45.1 $2,454 - $2,706	60 Added 0.72%	8,364 $370,000
Q4 2021 Jan 31, 2022	BUY	$38.07 - $44.87 $5,824 - $6,865	153 Added 1.88%	8,304 $353,000
Q2 2021 Aug 10, 2021	SELL	$38.58 - $44.24 $9,259 - $10,617	-240 Reduced 2.86%	8,151 $349,000
Q1 2021 May 07, 2021	BUY	$35.27 - $39.67 $19,398 - $21,818	550 Added 7.01%	8,391 $324,000
Q4 2020 Feb 10, 2021	SELL	$33.15 - $41.97 $1.14 Million - $1.44 Million	-34,360 Reduced 81.42%	7,841 $282,000
Q3 2020 Nov 02, 2020	BUY	$34.44 - $42.23 $482,745 - $591,937	14,017 Added 49.73%	42,201 $1.61 Million
Q2 2020 Aug 10, 2020	BUY	$30.19 - $39.11 $185,819 - $240,722	6,155 Added 27.94%	28,184 $990,000
Q1 2020 May 05, 2020	BUY	$25.83 - $45.71 $55,482 - $98,185	2,148 Added 10.8%	22,029 $719,000
Q4 2019 Feb 14, 2020	BUY	$37.87 - $45.37 $16,549 - $19,826	437 Added 2.25%	19,881 $899,000
Q3 2019 Nov 05, 2019	SELL	$40.31 - $43.45 $54,337 - $58,570	-1,348 Reduced 6.48%	19,444 $791,000
Q2 2019 Aug 13, 2019	SELL	$34.91 - $42.98 $69,785 - $85,917	-1,999 Reduced 8.77%	20,792 $894,000
Q1 2019 May 13, 2019	SELL	$32.91 - $40.75 $6,713 - $8,313	-204 Reduced 0.89%	22,791 $823,000
Q4 2018 Jan 29, 2019	SELL	$31.73 - $39.04 $67,489 - $83,038	-2,127 Reduced 8.47%	22,995 $813,000
Q3 2018 Nov 13, 2018	BUY	$32.83 - $38.63 $43,499 - $51,184	1,325 Added 5.57%	25,122 $967,000
Q2 2018 Aug 02, 2018	BUY	$26.84 - $34.32 $12,292 - $15,718	458 Added 1.96%	23,797 $778,000
Q1 2018 May 04, 2018	SELL	$25.2 - $28.54 $179,953 - $203,804	-7,141 Reduced 23.43%	23,339 $638,000
Q4 2017 Feb 08, 2018	SELL	$24.79 - $29.8 $65,048 - $78,195	-2,624 Reduced 7.93%	30,480 $756,000
Q3 2017 Nov 08, 2017	SELL	$26.26 - $29.17 $761 - $845	-29 Reduced 0.09%	33,104 $965,000
Q2 2017 Aug 11, 2017	BUY	N/A	33,133	33,133 $0

Others Institutions Holding BSX

# of Institutions

1,918

Shares Held

1.26B

Call Options Held

9.73M

Put Options Held

7.17M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $140B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D.A. Davidson & Co., based on Form 13F filings with the SEC.

News

Stay updated on D.A. Davidson & Co. with notifications on news.

Account